Numerous studies indicate that dietary supplementation with n-3 fatty
acids reduces the incidence of and morbidity associated with cardiovas
cular disease in middle-aged men. From these studies and the few trial
s conducted in older people, it can be assumed that the elderly may al
so benefit from the short-term effects of a moderate increase in the c
onsumption of fish, such as reductions in platelet aggregation, plasma
triglyceride levels and blood pressure. More clinical trials are need
ed to evaluate the beneficial long-term effects and the safety of incr
eased n-3 fatty acid intake in the elderly, especially that of higher,
pharmacological doses.